IRIS International, Inc. engages in the design, development, manufacture, and marketing of in vitro diagnostics (IVD) systems, consumables, and supplies for urinalysis and body fluids testing. It primarily offers diagnostics products, including iQ200 and iQ200 sprint automated urine microscopy analyzers; urine chemistry strips products for instruments and visual read strips; and workstations that perform microscopy and chemistry testing. The company provides consumables, including urine and body fluids reagents; calibrators and controls for its microscopy systems; and test strips, calibrators, controls, and other solutions for the urine chemistry analyzers. IRIS International also offers centrifuges, semiautomated DNA processing workstations, and blood analysis products. In addition, it conducts government-sponsored research and development in medical imaging and software, as well as pursues contract research for corporate clients. The company offers its products to hospitals, medical institutions, commercial laboratories, clinics, doctors’ offices, veterinary laboratories, and research facilities worldwide. It sells directly in the United States and through distributors internationally. The company was incorporated in 1979. It was formerly known as International Remote Imaging Systems, Inc. and changed its name to IRIS International, Inc. in 2003. IRIS International is headquartered in Chatsworth, California.
اخر سعر له اليوم 10.95
يتداول حاليا في الافتر اورز 11.50
السهم
LONG
اخر سعر له اليوم 10.95
يتداول حاليا في الافتر اورز 11.50
السهم
LONG
